title: Quality of life after haematopoietic stem cell transplantation in a multiracial population.
abstract: Haematopoietic stem cell transplantation (HSCT) was started in Malaysia since 1993 and it has improved the survival of patients with otherwise fatal haematological diseases. This study was initiated because quality of life of these survivors is an important tool in assessing the outcome of this treatment modality. The secondary objective was to identify factors that influenced their quality of life. The European Organization of Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-30) was used to assess the quality of life of eligible patients. A total of 62 patents were recruited. The mean global health score (QoL) was 71.2. The major symptoms faced by our patients were fatigue, financial difficulty and appetite loss. Appetite loss was an independent adverse factor for lower QoL.
authors.affiliation: University Malaya Medical Center, Kuala Lumpur, Malaysia. bpingchong@yahoo.com
authors.forename: P C
authors.initials: PC
authors.lastname: Bee
authors.forename: G G
authors.initials: GG
authors.lastname: Gan
authors.forename: V J
authors.initials: VJ
authors.lastname: Sangkar
authors.forename: A R
authors.initials: AR
authors.lastname: Haris
authors.forename: E
authors.initials: E
authors.lastname: Chin
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D003430:Cross-Sectional Studies; D005006:Ethnicity; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016014:Linear Models; D008296:Malaysia; D008297:Male; D011788:Quality of Life; D011795:Surveys and Questionnaires